Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies
View/ Open
Author
Liu, Xiaochuan
Wang, Aoli
Liang, Xiaofei
Liu, Juanjuan
Zou, Fengming
Chen, Cheng
Zhao, Zheng
Deng, Yuanxin
Wu, Hong
Qi, Ziping
Wang, Beilei
Wang, Li
Liu, Feiyang
Xu, Yunhe
Wang, Wenchao
Fernandes, Stacey M.
Galinsky, Ilene A.
Loh, Teckpeng
Griffin, James. D.
Zhang, Shanchun
Zhang, Xin
Liu, Jing
Liu, Qingsong
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.18632/oncotarget.10650Metadata
Show full item recordCitation
Liu, X., A. Wang, X. Liang, J. Liu, F. Zou, C. Chen, Z. Zhao, et al. 2016. “Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.” Oncotarget 7 (33): 53515-53525. doi:10.18632/oncotarget.10650. http://dx.doi.org/10.18632/oncotarget.10650.Abstract
PI3Kδ has been found to be over-expressed in B-Cell-related malignancies. Despite the clinical success of the first selective PI3Kδ inhibitor, CAL-101, inhibition of PI3Kδ itself did not show too much cytotoxic efficacy against cancer cells. One possible reason is that PI3Kδ inhibition induced autophagy that protects the cells from death. Since class III PI3K isoform PIK3C3/Vps34 participates in autophagy initiation and progression, we predicted that a PI3Kδ and Vps34 dual inhibitor might improve the anti-proliferative activity observed for PI3Kδ-targeted inhibitors. We discovered a highly potent ATP-competitive PI3Kδ/Vps34 dual inhibitor, PI3KD/V-IN-01, which displayed 10-1500 fold selectivity over other PI3K isoforms and did not inhibit any other kinases in the kinome. In cells, PI3KD/V-IN-01 showed 30-300 fold selectivity between PI3Kδ and other class I PI3K isoforms. PI3KD/V-IN-01 exhibited better anti-proliferative activity against AML, CLL and Burkitt lymphoma cell lines than known selective PI3Kδ and Vps34 inhibitors. Interestingly, we observed FLT3-ITD AML cells are more sensitive to PI3KD/V-IN-01 than the FLT3 wt expressing cells. In AML cell inoculated xenograft mouse model, PI3KD/V-IN-01 exhibited dose-dependent anti-tumor growth efficacies. These results suggest that dual inhibition of PI3Kδ and Vps34 might be a useful approach to improve the PI3Kδ inhibitor's anti-tumor efficacy.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288202/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731791
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)